4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-23-042795
Director acquired 46,630 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pacala Mark L Director | 2023-12-26 | Grant or award | +46,630 | 135,029 | D |
Loading xslF345X05/wk-form4_1703797778.xml…